Bortezomib protects from varicose-like venous remodeling

Despite the high prevalence of venous diseases that are associated with and based on the structural reorganization of the venous vessel wall, not much is known about their mechanistic causes. In this context, we demonstrated that the quantity of myocardin, a transcriptional regulator of the contract...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Pfisterer, Larissa (VerfasserIn) , Meyer, Ralph (VerfasserIn) , Feldner, Anja (VerfasserIn) , Drews, Oliver (VerfasserIn) , Hecker, Markus (VerfasserIn) , Korff, Thomas (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 25 April 2014
In: The FASEB journal
Year: 2014, Jahrgang: 28, Heft: 8, Pages: 3518-3527
ISSN:1530-6860
DOI:10.1096/fj.14-250464
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1096/fj.14-250464
Verlag, lizenzpflichtig, Volltext: https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fj.14-250464
Volltext
Verfasserangaben:Larissa Pfisterer, Ralph Meyer, Anja Feldner, Oliver Drews, Markus Hecker, and Thomas Korff

MARC

LEADER 00000caa a2200000 c 4500
001 1728771668
003 DE-627
005 20230426091331.0
007 cr uuu---uuuuu
008 200903s2014 xx |||||o 00| ||eng c
024 7 |a 10.1096/fj.14-250464  |2 doi 
035 |a (DE-627)1728771668 
035 |a (DE-599)KXP1728771668 
035 |a (OCoLC)1341358118 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Pfisterer, Larissa  |e VerfasserIn  |0 (DE-588)1038798302  |0 (DE-627)766549577  |0 (DE-576)392837439  |4 aut 
245 1 0 |a Bortezomib protects from varicose-like venous remodeling  |c Larissa Pfisterer, Ralph Meyer, Anja Feldner, Oliver Drews, Markus Hecker, and Thomas Korff 
264 1 |c 25 April 2014 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 03.09.2020 
520 |a Despite the high prevalence of venous diseases that are associated with and based on the structural reorganization of the venous vessel wall, not much is known about their mechanistic causes. In this context, we demonstrated that the quantity of myocardin, a transcriptional regulator of the contractile and quiescent smooth muscle cell phenotype, was diminished in proliferating synthetic venous smooth muscle cells (VSMCs) of human and mouse varicose veins by 51 and 60%, respectively. On the basis of the relevance of proteasomal activity for such phenotypic changes, we hypothesized that the observed VSMC activation is attenuated by the proteasome inhibitor bortezomib. This drug fully abolished VSMC proliferation and loss of myocardin in perfused mouse veins and blocked VSMC invasion in collagen gels by almost 80%. In line with this, topical transdermal treatment with bortezomib diminished VSMC proliferation by 80%, rescued 90% of VSMC myocardin abundance, and inhibited varicose-like venous remodeling by 67 to 72% in a mouse model. Collectively, our data indicate that the proteasome plays a pivotal role in VSMC phenotype changes during venous remodeling processes. Its inhibition protects from varicose-like vein remodeling in mice and may thus serve as a putative therapeutic strategy to treat human varicose veins.—Pfisterer, L., Meyer, R., Feldner, A., Drews, O., Hecker, M., Korff, T. Bortezomib protects from varicose-like venous remodeling. FASEB J. 28, 3518-3527 (2014). www.fasebj.org 
650 4 |a myocardin 
650 4 |a proteasome 
650 4 |a varicose veins 
650 4 |a venous smooth muscle cell phenotype 
700 1 |a Meyer, Ralph  |e VerfasserIn  |0 (DE-588)1211190013  |0 (DE-627)1699024413  |4 aut 
700 1 |a Feldner, Anja  |e VerfasserIn  |0 (DE-588)1028225466  |0 (DE-627)730466604  |0 (DE-576)37572317X  |4 aut 
700 1 |a Drews, Oliver  |d 1974-  |e VerfasserIn  |0 (DE-588)129902098  |0 (DE-627)483349453  |0 (DE-576)297894587  |4 aut 
700 1 |a Hecker, Markus  |d 1960-  |e VerfasserIn  |0 (DE-588)1071693344  |0 (DE-627)826266037  |0 (DE-576)433260319  |4 aut 
700 1 |a Korff, Thomas  |e VerfasserIn  |0 (DE-588)1048734951  |0 (DE-627)781211824  |0 (DE-576)386952604  |4 aut 
773 0 8 |i Enthalten in  |a Federation of American Societies for Experimental Biology  |t The FASEB journal  |d Hoboken, NJ : Wiley, 1987  |g 28(2014), 8, Seite 3518-3527  |h Online-Ressource  |w (DE-627)266889816  |w (DE-600)1468876-1  |w (DE-576)075962527  |x 1530-6860  |7 nnas 
773 1 8 |g volume:28  |g year:2014  |g number:8  |g pages:3518-3527  |g extent:10  |a Bortezomib protects from varicose-like venous remodeling 
856 4 0 |u https://doi.org/10.1096/fj.14-250464  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://faseb.onlinelibrary.wiley.com/doi/abs/10.1096/fj.14-250464  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200903 
993 |a Article 
994 |a 2014 
998 |g 129902098  |a Drews, Oliver  |m 129902098:Drews, Oliver  |p 4 
998 |g 1048734951  |a Korff, Thomas  |m 1048734951:Korff, Thomas  |d 50000  |d 53200  |e 50000PK1048734951  |e 53200PK1048734951  |k 0/50000/  |k 1/50000/53200/  |p 6  |y j 
998 |g 1071693344  |a Hecker, Markus  |m 1071693344:Hecker, Markus  |d 50000  |d 53200  |e 50000PH1071693344  |e 53200PH1071693344  |k 0/50000/  |k 1/50000/53200/  |p 5 
998 |g 1028225466  |a Feldner, Anja  |m 1028225466:Feldner, Anja  |d 50000  |d 53200  |e 50000PF1028225466  |e 53200PF1028225466  |k 0/50000/  |k 1/50000/53200/  |p 3 
998 |g 1211190013  |a Meyer, Ralph  |m 1211190013:Meyer, Ralph  |d 50000  |d 53200  |e 50000PM1211190013  |e 53200PM1211190013  |k 0/50000/  |k 1/50000/53200/  |p 2 
998 |g 1038798302  |a Pfisterer, Larissa  |m 1038798302:Pfisterer, Larissa  |d 50000  |d 53200  |e 50000PP1038798302  |e 53200PP1038798302  |k 0/50000/  |k 1/50000/53200/  |p 1  |x j 
999 |a KXP-PPN1728771668  |e 3746195802 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Gesehen am 03.09.2020"],"title":[{"title":"Bortezomib protects from varicose-like venous remodeling","title_sort":"Bortezomib protects from varicose-like venous remodeling"}],"person":[{"roleDisplay":"VerfasserIn","family":"Pfisterer","display":"Pfisterer, Larissa","given":"Larissa","role":"aut"},{"given":"Ralph","role":"aut","family":"Meyer","display":"Meyer, Ralph","roleDisplay":"VerfasserIn"},{"role":"aut","given":"Anja","roleDisplay":"VerfasserIn","display":"Feldner, Anja","family":"Feldner"},{"roleDisplay":"VerfasserIn","family":"Drews","display":"Drews, Oliver","role":"aut","given":"Oliver"},{"family":"Hecker","display":"Hecker, Markus","roleDisplay":"VerfasserIn","role":"aut","given":"Markus"},{"given":"Thomas","role":"aut","family":"Korff","display":"Korff, Thomas","roleDisplay":"VerfasserIn"}],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"id":{"doi":["10.1096/fj.14-250464"],"eki":["1728771668"]},"physDesc":[{"extent":"10 S."}],"recId":"1728771668","name":{"displayForm":["Larissa Pfisterer, Ralph Meyer, Anja Feldner, Oliver Drews, Markus Hecker, and Thomas Korff"]},"relHost":[{"note":["Gesehen am 12.05.2020","Fortsetzung der Druck-Ausgabe"],"title":[{"title_sort":"FASEB journal","subtitle":"the journal of the Federation of American Societies for Experimental Biology","title":"The FASEB journal"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"language":["eng"],"id":{"eki":["266889816"],"issn":["1530-6860"],"zdb":["1468876-1"],"doi":["10.1096/(ISSN)1530-6860"]},"physDesc":[{"extent":"Online-Ressource"}],"recId":"266889816","titleAlt":[{"title":"Journal"}],"part":{"text":"28(2014), 8, Seite 3518-3527","issue":"8","extent":"10","year":"2014","pages":"3518-3527","volume":"28"},"corporate":[{"display":"Federation of American Societies for Experimental Biology","roleDisplay":"VerfasserIn","role":"aut"}],"origin":[{"dateIssuedKey":"1987","publisherPlace":"Hoboken, NJ ; Bethesda, Md.","publisher":"Wiley ; FASEB","dateIssuedDisp":"1987-"}],"disp":"Federation of American Societies for Experimental BiologyThe FASEB journal","pubHistory":["1.1987 -"]}],"origin":[{"dateIssuedKey":"2014","dateIssuedDisp":"25 April 2014"}]} 
SRT |a PFISTERERLBORTEZOMIB2520